Slater Technology Fund — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Octagon Therapeutics, Inc.Feb 2024SEC filingmedium confidence
BiotechProvidence, US
Isaac Stoner(Executive Officer, Director)Thorne Sparkman(Director)Ronald Lennox(Director)
Board seatThorne Sparkman· per SEC Form D · $12.4M raise · filed Feb 2024
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.